Application no. and date | 18709132.7 (espacenet) (Federated) (European Patent Register), 20180105 | Patent/reg. no. and date | DK/EP 3601533, 20210224 | Publication date | 20200205 | Priority no. and date | US 201762478506 P, 20170329, US 201762539410 P, 20170731, US 201762548306 P, 20170821, US 201762554538 P, 20170905, US 201762559374 P, 20170915, US 201762567121 P, 20171002, US 201762577655 P, 20171026, US 201762582874 P, 20171107, US 201762596374 P, 20171208 | EP pub. no. and date |
EP 3601533 20200205 | Effective date | | Applicant/owner | Iovance Biotherapeutics, Inc., 999 Skyway Road Suite 150
San Carlos, CA 94070, US | Applicant ref. no. | V2104-044-DK | Inventor | LOTZE, Michael, T., 5134 Westminster Place
Pittsburgh, PA 15232, US, BENDER, James, 3 Cloverdale
Rancho Santa Margarita, CA 92688, US, WARDELL, Seth, 30204 USF Holly Drive
Tampa, FL 33620, US | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | Opponent | | IPC Class | C12M 1/04 (2006.01) , C12N 5/0783 (2010.01) | Title | FREMGANGSMÅDER TIL FREMBRINGELSE AF TUMORINFILTRERENDE LYMFOCYTTER OG ANVENDELSER AF SAMME I IMMUNOTERAPI | Int. application no. | US2018012633 | Int. publication no. | WO2018182817 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|